Literature DB >> 36217571

Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.

Jiwon Jung1,2, Jungmin Lee3, Sun-Kyung Kim2, Soyeon Park2, Young-Ju Lim2, Eun Ok Kim2, Heedo Park3, Man-Seong Park4, Sung-Han Kim1,5.   

Abstract

BACKGROUND: Patients with hematologic malignancies may produce replication-competent virus beyond 20 days of SARS-CoV-2 infection. However, data regarding the transmission of SARS-CoV-2 from patients with prolonged viral shedding is limited.
METHODS: In May 2022, four additional cases of COVID-19 were reported in a hematologic ward at a tertiary care hospital in South Korea, after an 8-week isolation of a patient with prolonged viral shedding. We performed whole-genome sequencing (WGS) of SARS-CoV-2 to evaluate the possibility of post-isolation transmission from this prolonged viral shedding.
RESULTS: A patient (case 1) with acute myeloid leukemia was released from isolation 54 days after the diagnosis of COVID-19 based on rising Ct value of up to 29.3, and moved to a six-patient room. On days 10 and 11 post-isolation, his doctor (case 2) and 2 patients who were his roommates (case 3, 4) had positive SARS-CoV-2 PCR results. Additionally, 16 days post-isolation, another patient (case 5) in a remote room had positive SARS-CoV-2 PCR result. All the three patients were hospitalized for ≥ 14 days when they were diagnosed with SARS-CoV-2 infection. Except for case 3, the remaining 4 cases were available for WGS, which revealed that case 1 exhibited a 7 nucleotides difference in comparison to cases 4 and 5 and case 2 displayed a 20 nucleotides difference compared with case 1, while sequences of cases 4 and 5 were identical.
CONCLUSIONS: Despite the possibility of transmission from the patient with prolonged viral shedding, no evidence of the transmission of SARS-CoV-2 from the patient with prolonged positive RT-PCR using WGS was found.
© 2022 The Korean Academy of Medical Sciences.

Entities:  

Keywords:  COVID-19; Hematologic Malignancy; Post-Isolation Transmission; SARS-CoV-2; Whole-Genome Sequencing

Mesh:

Substances:

Year:  2022        PMID: 36217571      PMCID: PMC9550637          DOI: 10.3346/jkms.2022.37.e289

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   5.354


  8 in total

1.  Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19.

Authors:  Ji Yeun Kim; Joon-Yong Bae; Seongman Bae; Hye Hee Cha; Ji-Soo Kwon; Mi Hyun Suh; Hyun Jung Lee; Jiwon Jung; Min Jae Kim; Chunguang Cui; Heedo Park; Jungmin Lee; Man-Seong Park; Sung-Han Kim
Journal:  Clin Microbiol Infect       Date:  2021-08-13       Impact factor: 8.067

2.  Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient.

Authors:  Jiwon Jung; Jungmin Lee; Heedo Park; Young-Ju Lim; Eun Ok Kim; Man-Seong Park; Sung-Han Kim
Journal:  J Korean Med Sci       Date:  2022-05-02       Impact factor: 5.354

3.  A SARS-CoV-2 Cluster in an Acute Care Hospital.

Authors:  Michael Klompas; Meghan A Baker; Chanu Rhee; Robert Tucker; Karen Fiumara; Diane Griesbach; Carin Bennett-Rizzo; Hojjat Salmasian; Rui Wang; Noah Wheeler; Glen R Gallagher; Andrew S Lang; Timelia Fink; Stephanie Baez; Sandra Smole; Larry Madoff; Eric Goralnick; Andrew Resnick; Madelyn Pearson; Kathryn Britton; Julia Sinclair; Charles A Morris
Journal:  Ann Intern Med       Date:  2021-02-09       Impact factor: 25.391

4.  Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.

Authors:  Teresa Aydillo; Ana S Gonzalez-Reiche; Sadaf Aslam; Adriana van de Guchte; Zenab Khan; Ajay Obla; Jayeeta Dutta; Harm van Bakel; Judith Aberg; Adolfo García-Sastre; Gunjan Shah; Tobias Hohl; Genovefa Papanicolaou; Miguel-Angel Perales; Kent Sepkowitz; N Esther Babady; Mini Kamboj
Journal:  N Engl J Med       Date:  2020-12-01       Impact factor: 91.245

5.  Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.

Authors:  Abby Sung; Adam L Bailey; Henry B Stewart; David McDonald; Meghan A Wallace; Kate Peacock; Candace Miller; Kimberly A Reske; Caroline A O'Neil; Victoria J Fraser; Michael S Diamond; Carey-Ann D Burnham; Hilary M Babcock; Jennie H Kwon
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 5.293

6.  Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.

Authors:  Sissy Therese Sonnleitner; Martina Prelog; Stefanie Sonnleitner; Eva Hinterbichler; Hannah Halbfurter; Dominik B C Kopecky; Giovanni Almanzar; Stephan Koblmüller; Christian Sturmbauer; Leonard Feist; Ralf Horres; Wilfried Posch; Gernot Walder
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

7.  Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.

Authors:  Maureen Lynch; Guerrino Macori; Séamus Fanning; Edel O'Regan; Eoin Hunt; Dermot O'Callaghan; Brian McCullagh; Cormac Jennings; Anne Fortune
Journal:  Emerg Infect Dis       Date:  2021-06-23       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.